PendingRTVA

Sviatlana Zyhmantovich Cell therapy developer Artiva Biotherapeutics (ARTV), whose collaborators include German biotech Affimed (AFMD), has filed with the SEC to raise up to $100M in an initial public offering under the ticker symbol “ARTV.” The San Diego, California-based biotech previously filed for a $100M IPO in 2021 to listContinue Reading